5-HT3 receptor antagonists ameliorate fatigue: so much potential, so little knowledge!
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 16009677.
- Also identified by PMC identifier 1774874.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
There is growing evidence that 5-HT3 receptor blockade will benefit patients with fatigue. Further research is needed to determine the mechanism underlying this widespread clinically important symptom and therapies may be derived from targeting the 5-HT system.
Medical subject headings
- Fatigue
- Serotonin Antagonists